Does adding ATG to the GVHD prophylaxis regimen help reduce its incidence?
Ayas
M
M
Al-Mahr
Mohamad
M
Al-Jefri
Abdullah
A
Rifai
Samira
S
Solh
Hassan
H
D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D005199:Fanconi Anemia / Q000628:therapy*; D006086:Graft vs Host Disease / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D015994:Incidence; D033581:Stem Cell Transplantation / Q000009:adverse effects; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum